Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 226

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

Open access
Gudbjartsson, Daniel F., Thorgeirsson, Gudmundur, Sulem, Patrick, Helgadottir, Anna, Gylfason, Arnaldur, Saemundsdottir, Jona, Bjornsson, Eythor, Norddahl, Gudmundur L., Jonasdottir, Aslaug, Jonasdottir, Adalbjorg, Eggertsson, Hannes P., Gretarsdottir, Solveig, Thorleifsson, Gudmar, Indridason, Olafur S., Palsson, Runolfur, Jonasson, Fridbert, Jonsdottir, Ingileif, Eyjolfsson, Gudmundur I., Sigurdardottir, Olof, Olafsson, Isleifur, Danielsen, Ragnar, Matthiasson, Stefan E., Kristmundsdottir, Snaedis, Halldorsson, Bjarni V., Hreidarsson, Astradur B., Valdimarsson, Einar M., Gudnason, Thorarinn, Benediktsson, Rafn, Steinthorsdottir, Valgerdur, Thorsteinsdottir, Unnur, Holm, Hilma, Stefansson, Kari · 2019 · Journal of the American College of Cardiology

Abstract

BACKGROUND: Lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular diseases that has no established therapy. The attribute of Lp(a) that affects cardiovascular risk is not established. Low levels of Lp(a) have been associated with type 2 diabetes (T2D). OBJECTIVES: This study investigated whether cardiovascular risk is conferred by Lp(a) molar concentration or apolipoprotein(a) [apo(a)] size, and whether the relationship between Lp(a) and T2D risk is causal. METHODS: This was a case-control study of 143,087 Icelanders with genetic information, including 17,715 with coronary artery disease (CAD) and 8,734 with T2D. This study used measured and genetically imputed Lp(a) molar concentration, kringle IV type 2 (KIV-2) repeats (which determine apo(a) size), and a splice variant in LPA associated with small apo(a) but low Lp(a) molar concentration to disentangle the relationship between Lp(a) and cardiovascular risk. Loss-of-function homozygotes and other subjects genetically predicted to have low Lp(a) levels were evaluated to assess the relationship between Lp(a) and T2D. RESULTS: Lp(a) molar concentration was associated dose-dependently with CAD risk, peripheral artery disease, aortic valve stenosis, heart failure, and lifespan. Lp(a) molar concentration fully explained the Lp(a) association with CAD, and there was no residual association with apo(a) size. Homozygous carriers of loss-of-function mutations had little or no Lp(a) and increased the risk of T2D. CONCLUSIONS: Molar concentration is the attribute of Lp(a) that affects risk of cardiovascular diseases. Low Lp(a) concentration (bottom 10%) increases T2D risk. Pharmacologic reduction of Lp(a) concentration in the 20% of individuals with the greatest concentration down to the population median is predicted to decrease CAD risk without increasing T2D risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.10.019

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 226

Metadata

Authors
Gudbjartsson, D. F., Thorgeirsson, G., Sulem, P., Helgadottir, A., Gylfason, A., Saemundsdottir, J., Bjornsson, E., Norddahl, G. L., Jonasdottir, A., Jonasdottir, A., Eggertsson, H. P., Gretarsdottir, S., Thorleifsson, G., Indridason, O. S., Palsson, R., Jonasson, F., Jonsdottir, I., Eyjolfsson, G. I., Sigurdardottir, O., Olafsson, I., Danielsen, R., Matthiasson, S. E., Kristmundsdottir, S., Halldorsson, B. V., Hreidarsson, A. B., Valdimarsson, E. M., Gudnason, T., Benediktsson, R., Steinthorsdottir, V., Thorsteinsdottir, U., Holm, H., & Stefansson, K.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-12
Volume
74
Issue
24
Pages
2982-2994
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2992833268
Cited by
226
References
11
FWCI
21.17
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes. https://app.cochat.ai/papers/10.1016/j.jacc.2019.10.019
The paper
Gudbjartsson, D. F., Thorgeirsson, G., Sulem, P., Helgadottir, A., Gylfason, A., Saemundsdottir, J., Bjornsson, E., Norddahl, G. L., Jonasdottir, A., Jonasdottir, A., Eggertsson, H. P., Gretarsdottir, S., Thorleifsson, G., Indridason, O. S., Palsson, R., Jonasson, F., Jonsdottir, I., Eyjolfsson, G. I., Sigurdardottir, O., . . . Stefansson, K. (2019). Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2019.10.019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.